• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2200202 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs License Renew 2022-07-18 AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG view
JYHZ2100595 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs License Renew 2021-08-05 Abbvie Deutschland Gmbh & Co KG view
JYHZ2000003 利托那韦片 ritonavir Tablet Chemical Drugs License Renew 2020-01-19 AbbVie Deutschland GmbH & Co. KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-08-06 view
JYHZ1700275 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs License Renew 2017-08-21 AbbVie Ltd. Abbvie Ltd;Abbvie Deutschland Gmbh & Co KG Certificate Issued 2018-03-19 view
JYHS2300031 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs(5.2) Import Drug Application 2023-02-22 Hetero Labs Ltd;Hainan Sihuan Pharmaceutical Co Ltd view
JYHS2300030 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs(5.2) Import Drug Application 2023-02-22 Hetero Labs Ltd;Hainan Sihuan Pharmaceutical Co Ltd view
JYHS2300004 利托那韦片 ritonavir Tablet Chemical Drugs(5.2) Import Drug Application 2023-01-17 Hetero Labs Ltd;Hetero Phrma (Beijing) Co Limited view
JYHB2400141 奈玛特韦片/利托那韦片组合包装 nirmatrelvir;ritonavir Tablet Chemical Drugs Supplementary Application Pfizer Investment Co Ltd view
JYHB2002360 利托那韦片 ritonavir Tablet Chemical Drugs Supplementary Application 2020-11-23 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2021-02-02 view
JYHB2001606 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-08-28 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-11-24 view
JYHB2001605 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-08-28 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-11-24 view
JYHB2000914 利托那韦片 ritonavir Tablet Chemical Drugs Supplementary Application 2020-06-29 AbbVie Deutschland GmbH & Co. KG Abbvie Deutschland Gmbh & Co KG Filed 2020-07-01 view
JYHB2000638 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-05-27 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Filed 2020-06-09 view
JYHB2000637 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-05-27 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Filed 2020-06-09 view
JYHB1901350 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2019-11-13 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-01-20 view
JYHB1901349 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2019-11-13 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-01-20 view
JYHB1901176 利托那韦片 ritonavir Tablet Chemical Drugs Supplementary Application 2019-10-15 AbbVie Deutschland GmbH & Co. KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2019-12-25 view
JYHB1900272 利托那韦片 ritonavir Tablet Chemical Drugs Supplementary Application 2019-03-04 AbbVie Ltd. Abbvie Ltd;Abbvie Deutschland Gmbh & Co KG Certificate Issued 2019-05-13 view
JYHB1900178 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2019-02-12 AbbVie Deutschland GmbH & Co. KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2019-09-23 view
JYHB1900177 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2019-02-12 AbbVie Deutschland GmbH & Co. KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2019-09-23 view